From our CEO | Media | GlaxoSmithKline

From our CEO

Andrew Witty talks about openness, transparency and collaboration at Wellcome Trust - October 2012

Sir Andrew Witty gave a speech on 11 October 2012 about openness, transparency and collaboration at the Wellcome Trust offices in London. The following is an edited down version concentrating on the main themes of the speech.


Andrew Witty talks about low cost vaccines on the day of the GAVI pledging conference - June 2011


Andrew Witty speaks to BBC News about GSK’s recent offer to supply its rotavirus vaccine, Rotarix™, to the GAVI Alliance at a fraction of developed world prices. Mr Witty also joins the panel of the BBC’s current affairs programme ‘Newsnight’ to discuss the role of philanthropy in the modern world.

The following files require Windows Media Player to view:

BBC News and BBC Radio 4 interviews on low-cost vaccines – June 2011

BBC News GAVI Alliance

GSK CEO Andrew Witty tells BBC News and BBC Radio 4 Today programme about GSK’s offer to the GAVI Alliance to provide low-cost vaccines to help prevent rotavirus-related diarrhoea in children in the developing world.

GSK Going Global – CNBC US interview - May 2011


GSK CEO Andrew Witty describes GSK's business strategy and approach to improving global health to CNBC US in May 2011.

Health Affairs - January 2011


GSK CEO Andrew Witty shares his views on innovation in global health in the January 2011 edition of Health Affairs

The Innovation Challenge - November 2010


GSK CEO Andrew Witty featured in The Economist publication The World in 2011 published in November 2010

The Times Eureka 100 Science List - October 2010


GSK CEO Andrew Witty featured at number 14 in The Times 100 Science List published in October 2010.